Takeda Pharmaceutical Co., Ltd. (TAK)
18.34
+0.10
(+0.52%)
USD |
NYSE |
Aug 25, 14:11
Takeda Pharmaceutical Debt to Equity Ratio : 0.6536 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6536 |
| March 31, 2026 | 0.7371 |
| December 31, 2025 | 0.635 |
| September 30, 2025 | 0.6515 |
| June 30, 2025 | 0.6563 |
| March 31, 2025 | 0.7337 |
| December 31, 2024 | 0.6525 |
| September 30, 2024 | 0.7299 |
| June 30, 2024 | 0.7029 |
| March 31, 2024 | 0.7512 |
| December 31, 2023 | 0.6918 |
| September 30, 2023 | 0.6618 |
| June 30, 2023 | 0.6859 |
| March 31, 2023 | 0.7651 |
| December 31, 2022 | 0.6941 |
| September 30, 2022 | 0.7056 |
| June 30, 2022 | 0.7286 |
| March 31, 2022 | 0.8465 |
| December 31, 2021 | 0.8168 |
| September 30, 2021 | 0.7948 |
| June 30, 2021 | 0.8411 |
| March 31, 2021 | 0.9804 |
| December 31, 2020 | 1.025 |
| September 30, 2020 | 1.052 |
| June 30, 2020 | 1.083 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.156 |
| December 31, 2019 | 1.072 |
| September 30, 2019 | 1.033 |
| June 30, 2019 | 1.161 |
| March 31, 2019 | 1.144 |
| December 31, 2018 | 1.250 |
| September 30, 2018 | 0.4614 |
| June 30, 2018 | 0.4869 |
| March 31, 2018 | 0.5201 |
| December 31, 2017 | 0.5386 |
| September 30, 2017 | 0.5453 |
| June 30, 2017 | 0.5683 |
| March 31, 2017 | 0.6354 |
| December 31, 2016 | 0.4925 |
| September 30, 2016 | 0.5229 |
| June 30, 2016 | 0.5277 |
| March 31, 2016 | 0.4219 |
| December 31, 2015 | 0.3479 |
| September 30, 2015 | 0.344 |
| June 30, 2015 | 0.3386 |
| March 31, 2015 | 0.3504 |
| December 31, 2014 | 0.3646 |
| September 30, 2014 | 0.3572 |
| June 30, 2014 | 0.4032 |
| March 31, 2014 | 0.2897 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Ono Pharmaceutical Co., Ltd. | 0.1351 |
| Astellas Pharma, Inc. | 0.3036 |
| Sanofi | -- |
| Eisai Co., Ltd. | 0.2993 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 96.37B |
| Total Liabilities (Quarterly) | 49.87B |
| Shareholders Equity (Quarterly) | 46.50B |
| Current Ratio | 1.140 |
| Net Debt Paydown Yield | 1.43% |